Endothelial ADRB3 protects the heart from myocardial infarction by suppressing endothelial-to-mesenchymal transition
Cardiovascular Research · 31.10.2026
DOI: 10.1093/cvr/cvag261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 31.10.2026. Verfasst von Zebei Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hyper…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims β3 adrenergic receptor (ADRB3) has recently emerged as an important regulator of cardiovascular homeostasis. However, the role of endothelial ADRB3 in cardiac repair after myocardial infarction (MI) remains unclear. As endothelial dysfunction critically drives post-MI remodelling, we hypothesized that ADRB3 preserves endothelial integrity and protects the heart from ischaemic injury. Methods and results Endothelial cell-specific ADRB3 knockout mice and adeno-associated virus serotype 9 (AAV9)-mediated endothelial ADRB3 overexpression mice were subjected to MI. Single-cell RNA sequencing (scRNA-seq) was performed to characterize cellular heterogeneity and endothelial phenotypic changes. scRNA-seq revealed enhanced endothelial-to-mesenchymal transition (EndoMT) and activated TGFβ signalling in ADRB3-deficient hearts, accompanied by accelerated fibrotic remodelling and exacerbated ischaemic injury. In contrast, endothelial ADRB3 overexpression suppressed EndoMT, reduced fibrosis, and improved cardiac function following MI. In vitro, ADRB3 knockdown induced EndoMT and endothelial dysfunction, whereas ADRB3 overexpression attenuated hypoxia-induced mesenchymal activation. Mechanistically, proximity ligation assay, co-immunoprecipitation, and mass spectrometry identified TGFβ receptor 2 (TGFβR2) as an endogenous binding partner of ADRB3. ADRB3 interaction with TGFβR2 prevented SMAD2 recruitment to TGFβR1 and inhibited downstream SMAD2 phosphorylation. Moreover, endothelial-specific TGFβR2 knockdown using AAV9 mitigated cardiac injury in ADRB3-deficient mice following MI. Conclusion These findings demonstrate that endothelial ADRB3 protects against ischaemic heart injury by limiting TGFβR2-SMAD2-dependent EndoMT, highlighting its role as a critical endothelial regulator and a potential therapeutic target for myocardial repair.
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medi…
- Department of Medicine, Jagiellonian University, Colelgium Medicum, Krakow, Poland.
- Centre for Cardiovascular Sciences, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
- Shanghai Key Laboratory of Molecular Imaging, Zhoupu Hospital, Shanghai University of Medicine and Health Sciences, Shanghai, China.
ORCID-Profile: Tomasz Guzik
Zitieren
APA
Zhang, Z., Chen, X., Chen, X., Li, J., Zhai, Y., Guzik, T., Zheng, Y., Gao, P., & Lin, J. (2026). Endothelial ADRB3 protects the heart from myocardial infarction by suppressing endothelial-to-mesenchymal transition. Cardiovascular Research. https://doi.org/10.1093/cvr/cvag261
Vancouver
Zhang Z, Chen X, Chen X, Li J, Zhai Y, Guzik T, et al. Endothelial ADRB3 protects the heart from myocardial infarction by suppressing endothelial-to-mesenchymal transition. Cardiovascular Research. 2026. doi:10.1093/cvr/cvag261
BibTeX
@article{Zhang2026,
author = {Zhang, Zebei and Chen, Xiaoqing and Chen, Xiaohui and Li, Jiaqi and Zhai, Yonghua and Guzik, Tomasz and Zheng, Yanjun and Gao, Pingjin and Lin, Jingrong},
title = {Endothelial ADRB3 protects the heart from myocardial infarction by suppressing endothelial-to-mesenchymal transition},
journal = {Cardiovascular Research},
year = {2026},
doi = {10.1093/cvr/cvag261}
}
EUVIMED